Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Jayanth Sridhar , MD

Ophthalmology • Miami, FL

Active NPI 1366746166 Individual Practitioner Male Practitioner
Practice location in NPPES

900 Nw 17th St
Miami, FL 331361119

Call 3053266391 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

900 Nw 17th St

Miami, FL 331361119

Telephone 3053266391
Organization at the Same NPPES Address or Phone
University Of Miami Facility NPI 1972552495

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Medicare-allowed amount

About $49,351 in 2023

The total amount Medicare approved for these services in 2023. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.

Paid by Medicare

About $29,278 in 2023

The part of the Medicare-allowed amount that Medicare itself paid in 2023, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.

30-day fills

86 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$1,116 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $123,067.01 across 111 records.

By nature of payment (3 largest of 4)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $96,364.93 across 16 records.
  • Travel and Lodging: $15,074.45 across 43 records.
  • Consulting Fee: $9,425.00 across 6 records.

Reporting-company totals (3 largest of 7)

  • Regeneron Pharmaceuticals, Inc.: $106,474.44 across 93 records.
  • Genentech, Inc.: $9,920.04 across 9 records.
  • Alcon Research LLC: $3,500.00 across 3 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

NPI first issued

2011

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Medicare assignment not listed

CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Sridhar has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Sridhar as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Miami and Florida

Billing and prescribing volume is not a quality rating.

Medicare Part D prescriptions

Fewer Part D prescriptions than 85% of clinicians listed under Ophthalmology in Miami, FL (2024, 151 clinicians with data). Median for this group: 1,076. Middle half: 220 to 2,550.

Fewer Part D prescriptions than 90% of clinicians listed under Ophthalmology in Florida (2024, 1,099 clinicians with data). Median for this group: 1,203. Middle half: 442 to 2,490.

Part D drug cost

A lower Part D drug cost than 90% of clinicians listed under Ophthalmology in Miami, FL (2024, 151 clinicians with data). Median for this group: $82,567. Middle half: $7,940 to $309,842.

A lower Part D drug cost than 90% of clinicians listed under Ophthalmology in Florida (2024, 1,099 clinicians with data). Median for this group: $114,958. Middle half: $23,858 to $310,282.

Medicare Part B

Comparisons use 2024 data. The latest CMS data for Dr. Sridhar are from 2023.

223 active clinicians are listed under Ophthalmology with a practice address in Miami, FL (1,582 in Florida).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Miami

11.2% of these 223 clinicians have the CMS telehealth indicator.

60.1% of these 223 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2023), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 111 records totaling $123,067.01.

Manufacturer Payment Nature Product Type Amount ($)
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $9,400.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $9,400.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $9,400.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $9,400.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $9,400.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $9,400.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $8,930.00
Genentech, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
Vabysmo General $6,720.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $5,640.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $5,640.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $3,760.00
Genentech, Inc.
Consulting Fee
Cash or cash equivalent
Susvimo General $2,925.00
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $2,037.97
Alcon Research LLC
Consulting Fee
Cash or cash equivalent
— General $2,000.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $1,974.26
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $1,880.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $1,880.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $1,880.00
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $1,862.24
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $1,660.67
Ocular Therapeutix, Inc.
Consulting Fee
Cash or cash equivalent
— General $1,500.00
Alcon Vision LLC
Consulting Fee
Cash or cash equivalent
UNITY General $1,500.00
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $1,359.97
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $1,310.25
Alcon Research LLC
Consulting Fee
Cash or cash equivalent
NGENUITY General $1,000.00

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2023.

CMS Part B · Data Year 2023
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2022 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2023; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
92134 Imaging of retina
206 144 $105.00 $25.47
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
181 120 $193.00 $71.76
92134 Imaging of retina
118 88 $105.00 $25.46
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
95 65 $193.00 $71.76
67028 Injection of drug into eye
91 47 $413.41 $104.81
67028 Injection of drug into eye
50 30 $414.20 $105.64
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
30 30 $299.00 $105.58
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
27 27 $299.00 $105.62
92250 Photography of the retina
21 17 $88.00 $21.69

Source: CMS Part B by Provider and Service, 2023; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Latanoprost Latanoprost 26 847 $181.21 —
Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat 17 1,072 $139.53 —
Prednisolone Acetate Prednisolone Acetate 14 569 $795.67 —

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Ophthalmology Primary Specialty

NUCC Taxonomy Code: 207W00000X

License # reported to NPPES FL ME128049

An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.

Ophthalmology

NUCC Taxonomy Code: 207W00000X

License # reported to NPPES FL TRN15331

An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Florida Department of Health Medical Quality Assurance.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - OPHTHALMOLOGY

Medicare Enrollment ID

I20210817003243

Enrollment State Jurisdiction

CA

PECOS Control ID

4284854092

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

7 listed
NPI 1861042467

Doctor of Medicine (M.D.)

Dr. Diego Altamirano Medina , MD

Student in an Organized Health Care Education/Training Program

NPI 1972114445

Doctor of Medicine (M.D.)

NPI 1518690346

Doctor of Medicine (M.D.)

NPI 1356543086

Doctor of Medicine (M.D.)

NPI 1346602026

Doctor of Medicine (M.D.)

Dr. David Redick , MD

Student in an Organized Health Care Education/Training Program

NPI 1770078859

Doctor of Medicine (M.D.)

Career & Practice History

NPI enumerated January 07, 2011.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1366746166
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: January 07, 2011
Last Update: August 26, 2016
Sole Proprietor: No

Other Ophthalmology Specialists in Miami

All Ophthalmology Specialists in Miami

Mailing Address

320 Leucadendra Dr

Coral Gables, FL 331562329

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.